Importantly, the results of an in vitro study of a proximal tubule cell line suggested that in patients with CKD, IS, PCS, and KA might compete with commonly prescribed drugs for OAT1-mediated secretion.28 This evidence concerns the gene SLC22A6 and chronic kidney disease.